Hepatitis C and B - Management and Treatment

Chronic hepatitis C and B affect 520 million people worldwide, and are a major cause of chronic liver disease and of mortality, despite the efficacy of the vaccine. Hepatitis C and B : Management and Treatment, second edition, provides a practical explanation of the natural history and management of the diseases, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of biochemical markers and of the Treatment of various difficult-to-treat patients and will be a welcome guide to the physician in both clinical decision-making and explaining the benefits and side-effects to the patient.